ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml, dispersion à diluer pour perfusion — 1 flacon(s) en verre de 10 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930074152
  • CIP7 3007415
  • CIS 63390752
  • Registration number EU/1/16/1130

What the source publishes

Holder
LES LABORATOIRES SERVIER
Active ingredients
SEL DE SUCROSOFATE D'IRINOTÉCAN, IRINOTÉCAN
Form
dispersion à diluer pour perfusion
Package
1 flacon(s) en verre de 10 ml
Routes
intraveineuse
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2016-10-14
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930074152
{
  "cis": "63390752",
  "cip7": "3007415",
  "form": "dispersion à diluer pour perfusion",
  "name": "ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml, dispersion à diluer pour perfusion — 1 flacon(s) en verre de 10 ml",
  "cip13": "3400930074152",
  "holder": "LES LABORATOIRES SERVIER",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "LES LABORATOIRES SERVIER"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2016-10-14",
  "compositions": [
    {
      "name": "SEL DE SUCROSOFATE D'IRINOTÉCAN",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "58061",
      "dosageReference": null,
      "pharmaceuticalElement": "dispersion"
    },
    {
      "name": "IRINOTÉCAN",
      "nature": "FT",
      "strength": "4,3 mg",
      "linkageNumber": "1",
      "substanceCode": "73952",
      "dosageReference": "1 ml de dispersion",
      "pharmaceuticalElement": "dispersion"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/ml, dispersion à diluer pour perfusion",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon(s) en verre de 10 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2018-04-19",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SEL DE SUCROSOFATE D'IRINOTÉCAN",
    "IRINOTÉCAN"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/16/1130",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930074152"